US Patent 7572814 3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds
Patent 7572814 was granted and assigned to Cytokinetics on August, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Bradley P. Morgan0
David J. Morgans, Jr.0
Gustave Bergnes0
Jianchao Wang0
Luke Ashcraft0
Scott Collibee0
Zhe Yang0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+354 characters)
Article
Patent abstract
Certain 3,5-dibenzoyl-4-phenyl-piperidine compounds and salts thereof are provided herein. The compounds and salts may be useful in causing mitotic arrest and cell death. Also provided herein are certain pharmaceutical compositions comprising 3,5-dibenzoyl-4-phenyl-piperidine compounds or salts thereof and certain methods of use thereof.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07572814 3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds US Patent 7572814 3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds
Infobox
Patent Number
07572814
Patent Number
7572814
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07572814 3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07572814
Date of patent
August 11, 2009
Patent application number
11600684
Date Filed
November 15, 2006
Patent primary examiner
Find more entities like US Patent 7572814 3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.